Description
There is preclinical evidence that the detrimental cognitive effects of hormone loss can be ameliorated by estrogen therapy (Bimonte, Acosta, & Talboom, 2010), however, one of the primary concerns with current hormone therapies is that they are nonselective, leading to increased risk of breast and endometrial cancers as well as heart disease.
Copyright Statement
Download count: 0
Details
Contributors
- Whitton, Elizabeth Nicole (Author)
- Bimonte-Nelson, Heather (Thesis director)
- Presson, Clark (Committee member)
- Baxter, Leslie (Committee member)
- Barrett, The Honors College (Contributor)
- Department of Psychology (Contributor)
Date Created
The date the item was original created (prior to any relationship with the ASU Digital Repositories.)
2013-05
Subjects
Resource Type
Collections this item is in